Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

988 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
What do medical records tell us about potentially harmful co-prescribing?
Elston Lafata J, Simpkins J, Kaatz S, Horn JR, Raebel MA, Schultz L, Smith DH, Yood MU. Elston Lafata J, et al. Among authors: smith dh. Jt Comm J Qual Patient Saf. 2007 Jul;33(7):395-400. doi: 10.1016/s1553-7250(07)33045-6. Jt Comm J Qual Patient Saf. 2007. PMID: 17711141
Potential drug-drug interactions in the outpatient setting.
Lafata JE, Schultz L, Simpkins J, Chan KA, Horn JR, Kaatz S, Long C, Platt R, Raebel MA, Smith DH, Xi H, Yood MU. Lafata JE, et al. Among authors: smith dh. Med Care. 2006 Jun;44(6):534-41. doi: 10.1097/01.mlr.0000215807.91798.25. Med Care. 2006. PMID: 16708002
Prescription drug use in pregnancy.
Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R. Andrade SE, et al. Among authors: smith dh. Am J Obstet Gynecol. 2004 Aug;191(2):398-407. doi: 10.1016/j.ajog.2004.04.025. Am J Obstet Gynecol. 2004. PMID: 15343213
Use of prescription medications with a potential for fetal harm among pregnant women.
Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA, Fortman KK, McPhillips H, Roblin D, Smith DH, Yood MU, Platt R, H Gurwitz J. Andrade SE, et al. Among authors: smith dh. Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):546-54. doi: 10.1002/pds.1235. Pharmacoepidemiol Drug Saf. 2006. PMID: 16586470
Use of antidepressant medications during pregnancy: a multisite study.
Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R. Andrade SE, et al. Among authors: smith dh. Am J Obstet Gynecol. 2008 Feb;198(2):194.e1-5. doi: 10.1016/j.ajog.2007.07.036. Epub 2007 Oct 1. Am J Obstet Gynecol. 2008. PMID: 17905176
Outpatient use of cardiovascular drugs during pregnancy.
Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Dal Pan GJ, Scott PE, Platt R. Andrade SE, et al. Among authors: smith dh. Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):240-7. doi: 10.1002/pds.1550. Pharmacoepidemiol Drug Saf. 2008. PMID: 18200619
Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations.
Brown JS, Kulldorff M, Petronis KR, Reynolds R, Chan KA, Davis RL, Graham D, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Brown JS, et al. Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):226-34. doi: 10.1002/pds.1706. Pharmacoepidemiol Drug Saf. 2009. PMID: 19148879
988 results